Sign inJoin waitlistJoin the waitlist

Joel Mermis

Professor, Pulmonary, Critical Care and Sleep Medicine · University of Kansas School of Medicine

Credentials: · · · · ·

History

University of Kansas School of Medicine
Present
University of Kansas School of Medicine
Present

Pulmonary Disease and Critical Care Medicine
University of Kansas School of Medicine
2006–2009
Internal Medicine
Emory University
2003–2006
Univ of Kansas Sch of Med
1999–2003
Biochemistry, University of Kansas, Lawrence, Kansas

Research

Body mass index is associated with reduced exhaled nitric oxide and higher exhaled 8-isoprostanes in asthmatics
Respiratory Research · 2007 · 141 citations
Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and…
The Lancet Respiratory Medicine · 2025 · 92 citations
Hypoxia-inducible factor-1 α/platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling
Respiratory Research · 2011 · First of 9 authors · 60 citations

Deepika Polineni
5 papers
Steven Simpson
5 papers
Alex Gifford
2 papers
AO
Amy O’Brien-Ladner
2 papers
BJ
Badr Jandali
2 papers
Charlotte Teneback
2 papers
Edith Zemanick
2 papers
ED
Elliott Dasenbrook
2 papers
Emily DiMango
2 papers
Hossein Sadeghi
2 papers
JZ
Jonathan Zuckerman
2 papers
Natalie West
2 papers

Clinical trials

A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)
Site PI · Recruiting · Phase 1, Phase 2
Spirovant Sciences, Inc.
2024–2026
4D-710 in Adult Patients With Cystic Fibrosis
Site PI · Recruiting · Phase 2
4D Molecular Therapeutics
2022–2031